You will know well from history that real change won't happen by providing more federal money with unconditional transfers.Real change will require helping provinces to shift the focus of our health system away from those who are relatively well resourced to new areas of care, such as essential pharmaceuticals and homecare.
I was a hard rock miner at the time and fortunately my union, the United Steelworkers, had an Employee Assistance Program whose staff guided me to the treatment I needed. They accepted me as a person who has a problem, not a problem person, and put me on the road to recovering my sobriety and my dignity.
The glaring gaps in drug coverage for Canadian children are made stranger by the economic dimensions of the issue. Children's health care represents a drop in the ocean of health care budgets -- extending universal drug coverage to children would constitute a small fraction of total pharmaceutical spending.
I recently attended a mental health first aid course in order to further educate myself on the various mental illness disorders, the consequences of their severity and their overall prevalence in the population -- My eyes were opened to an entire population of our Canadian people whose rate of suicide was too horrifying to further ignore. As statistics related to aboriginal suicides were listed, I realized that this war being waged against the stigma of mental illness is but one of the many battles that will need to be addressed honestly in order to understand the magnitude of the affliction our mentally ill population is facing. As communities of aboriginals are fighting an invisible disease, society can dismiss the reality of the stigma by citing drugs and alcohol as the weak link in this people's history.
Fentanyl stole from me, from my family and from countless others across Canada. I've had items stolen from me before. In high school, someone broke into my locker and took my iPod. I remember my mom telling me, "Life goes on." Last year, someone stole funds from my bank account. Life goes on. Sometimes, though, it doesn't. On February 28, 2015, my older brother took what he thought was an Oxycontin tablet while he was out partying. He went home, he went to bed and he never woke up.
Why not show the seedy, disgusting underbelly and sickening adverse effects drugs have on us feeble humans? Images of a deviated septum, busted arm veins, chronic bleeding noses, rotten teeth, fetal effects, undernourished human bodies, etc. Horrifying images of what drug use has on the human body. Visceral images that make one think "that's repulsive, I'll never do that." We usher in a movement that illustrates and encourages dialogue about the revolting face of what drugs do: destroy the human spirit, decay our bodies, ruin families, and ultimately lead us to an early grave. There is NO glamour in drug use, no matter what Kanye is singing about.
Cities have to spend this money, taken from local taxpayers, because Canada's medicare system is the only universal, public health care system among developed countries that does not include universal coverage of prescription drugs. It is not wrong for cities to care for their employees. But leaving these costs to the cities makes about as much sense as requiring every homeowner to maintain the roads and infrastructure surrounding their property. Here's why.
A new study in the Canadian Medical Association Journal with health economist Steve Morgan as lead author argues a national universal care drug program would not result in substantial tax increases. It seems the time is ripe to finally complete our universal system of public healthcare coverage by adding a national public drug plan. If anything, these cautions should serve as guideposts to make sure a new national drug plan is not only effective but also designed in a fiscally sustainable manner.
The federal government plays a vital role in pharmaceutical drug regulation. We have many reasons to be proud of the systems for drug safety already in place in Canada. Yet there's room for significant improvement. Canadians deserve safe, effective, accessible and reliable pharmaceutical drugs when they need them. The only way to do this is through perpetually improved systems framed by transparency and openness.
Generally speaking, steroid users are not impressionable youth--they are young adults fully capable of making informed decisions about their own health. Steroid users are not devious cheaters--they are not involved with organized sport and are not bound by the rules of any sporting body. Steroid users are not less intelligent--they are professionals with more than average education. And steroid users bear little resemblance to addicts--they are seeking to improve their health, not feeding an addiction.
In a public healthcare system, too often system failures end up as fodder for Question Period battles rather than impetus for learning. When investments have been made in new models of health service funding and delivery that don't work out, it can be difficult to proclaim failure as a means to move toward success.
Employers want their drug plans to be as competitive as those offered by other employers. So what happens when the norm is to cover all new drugs at any cost, even if the drugs do not provide additional therapeutic value? Well, the end result is that everyone buys "generous" plans instead of increasing employee compensation. Everyone we spoke with agrees about the need to educate employees and employers alike. And in fact, everyone agrees (even insurers) that exorbitant drug costs are a big issue for Canadians.
Last week in Berlin more than 15 countries pledged over US$7.5 billion to buy vaccines for the children of the world's poorest countries for the next five years. While this is great news for the millions of children living in the 73 countries supported by Gavi, there were other big winners: the pharmaceutical companies that benefit from the soaring vaccine prices they charge for vaccines worldwide.
Although advertising of prescription medicines to the public is generally banned in Canada on public health grounds, shifts in administrative policy have allowed two types of ads since late 2000: "reminder" ads that mention a brand name, but make no health claims; and "help-seeking" ads that mention a condition, but do not state a brand or company name. We have identified six main weaknesses in how Health Canada regulates this advertising.